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Abstract
In vertebrates, little is known on the role of programmed cell death (PCD) occurring within the population of dividing neural precursors
and newly formed neuroblasts during early neural development. During primary neurogenesis, PCD takes place within the neuroectoderm
of Xenopus embryos in a reproducible stereotypic pattern, suggesting a role for PCD during the early development of the CNS. We find that
the spatio-temporal pattern of PCD is unaffected in embryos in which cell proliferation has been blocked and whose neuroecotoderm
contains half the normal number of cells. This shows that PCD is not dependent on cell division. It further suggests that PCD does not solely
function to regulate absolute cell numbers within the neuroectoderm. We demonstrate that PCD can be reproducibly inhibited in vivo during
primary neurogenesis by the overexpression of human Bcl-2. Following PCD inhibition, normal neurogenesis is disrupted, as seen by the
expansion of the expression domains of XSox-2, XZicr-2, XNgnr-1, XMyT-1, and N-Tubulin, XNgnr-1 being the most affected. PCD
inhibition, however, did not affect the outcome of lateral inhibition. We propose, then, that PCD regulates primary neurogenesis at the level
of neuronal determination.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Programmed cell death (PCD) is an important process,
taking place during the development of many tissues and
organs in both vertebrates and invertebrates. Most PCD
occurs via apoptosis, a well-characterized genetic program
that exhibits specific morphological features, such as mem-
brane blebbing, nuclear and cytoplasmic shrinkage, chro-
matin condensation, and DNA fragmentation (Kerr et al.,
1972). DNA fragmentation enables the detection of apopto-
tic cells in situ via the TUNEL (Terminal deoxynucleotidyl
transferase mediated dUTP Nick-End Labeling) technique
(Gavrieli et al., 1992). The key effector components of
apoptosis belong to a family of cysteine proteases named
the caspases. Caspases are activated by proteolytic cleavage
to form active oligomeric complexes, which then cleave
selected intracellular proteins at specific aspartate residues
(Nicholson and Thornberry, 1997). Thus, immunocyto-
chemistry with antibodies directed against activated forms
of caspases provides an alternative to TUNEL in the detec-
tion of apoptotic cells (Srinivasan et al., 1998).
Apoptosis is essential in the removal of structures such
as the intersegmental musculature in insects, the tail in
anurans during metamorphosis, or the interdigital mesen-
chyme in the development of the vertebrate limb (Jacobson
et al., 1997). Many neurons die via apoptosis during the
development of the peripheral nervous system, in the pro-
cess of establishing proper synaptic organization and axonal
pathways. PCD also participates in removing nonfunctional
or even potentially harmful cells such as nonreactive or
self-reactive B and T lymphocytes (Sanders and Wride,
1995).
The majority of studies on PCD in vertebrate develop-
ment have focused either on postembryonic or on late em-
bryonic development, while much less is known about the
roles of PCD during the early phases of gastrulation and
neurulation (Glucksmann, 1965; Jacobson et al., 1997). Re-
cent studies using TUNEL have highlighted the occurrence
of patterned PCD in the early stages of development in
zebrafish, Xenopus, and chick (Cole and Ross, 2001;
Hensey and Gautier, 1998; Hirata and Hall, 2000). In Xe-
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nopus, PCD is detected in a reproducible and dynamic
pattern within the embryo from late gastrulation to late
neurulation (Hensey and Gautier, 1998). Strikingly, PCD is
detected exclusively within the presumptive neuroectoderm
at the neural plate stage. As development proceeds, the
pattern of PCD becomes more defined, confined within the
anterior regions where the brain and sensory placodes will
eventually form, and within the neural folds that will give
rise to the spinal cord. At later stages, PCD remains local-
ized to specific brain regions, developing sensory organs
and the spinal cord. The reproducible and patterned cell
death occurring within the developing neural tissues at early
stages suggests a role for PCD in primary neurogenesis
(Hensey and Gautier, 1998).
Primary neurogenesis occurs as a cascade of events tak-
ing place following neural induction of the dorsal ectoderm.
Neural induction is mediated by the inhibition of BMPs by
secreted factors from the organizer such as Chordin, Nog-
gin, and Follistatin (Harland, 2000). Expression of early
neural genes, such as XSox-2, occurs within the induced
neuroectoderm, followed by the expression of XNgnr-1, a
bHLH determination factor of neuronal fate, within three
bilateral longitudinal domains within the neuroectoderm
(Chitnis, 1999). Lateral inhibition within these domains
restricts the number of neural cells specified to become
neurons. Cells specified to become neurons express the
Zn-finger neuronal specification factor XMyT-1, which en-
ables them to escape lateral inhibition and eventually un-
dergo neuronal differentiation, as seen by N-Tubulin expres-
sion (Sasai, 1998). Concomitant with this neurogenic
cascade, cell proliferation is taking place within the neuro-
ectoderm. Cell division occurs in a single wave, moving in
a lateral to medial direction from stages 12 to 16 in Xenopus
(Hartenstein, 1989).
Mice deficient in Casp-3, Casp-9, or Apaf-1 show de-
fects in PCD and die before birth, suggesting that PCD is
essential for proper embryonic development (Cecconi et al.,
1998; Hakem et al., 1998; Kuida et al., 1996, 1998; Yoshida
et al., 1998). The embryonic lethality could be due to the
hyperplasia in the brain, a possible consequence of the lack
of PCD in both undifferentiated neural precursors at the
early stage, and differentiated neurons that do not establish
the right synaptic connection in the later stages (Blaschke et
al., 1996; de la Rosa and de Pablo, 2000; Kuan et al., 2000).
We have successfully prevented the occurrence of PCD
in vivo during the early development of Xenopus embryos
through the expression of human Bcl-2. We find that inhi-
bition of PCD during early neurogenesis leads to the dis-
ruption of normal neurogenesis, resulting in the expansion
in both neural and neuronal cell types. PCD is abrogated
when neural cells are diverted from differentiation and
maintained in an uncommitted state by the overexpression
of constituitively active X-NotchICD, suggesting that PCD
participates in primary neurogenesis at the level of neuronal
determination. In addition, we show that the occurrence of
PCD is independent of cell proliferation, establishing that
its role is not limited to controlling the absolute cell number




Albino Xenopus laevis embryos were obtained by in
vitro fertilization and cultured using standard methods (Sive
et al., 1994). Embryos were staged according to Nieuwkoop
and Faber (1967).
Cell cycle inhibition
Embryos were dejellied in 2% cysteine, pH 7.8, grown to
stage 10.5–11.0, and treated with proteinase-K (Roche) at 5
g/ml for 5 min at room temperature to weaken the vitelline
membrane. To block DNA synthesis, embryos were incu-
bated in a solution of 20 mM hydroxyurea (Sigma) and 150
M aphidicolin (Sigma) in 0.1 MMR (HUA), as de-
scribed in Harris and Hartenstein (1991). Aphidicolin was
diluted from a 10 mg/ml frozen stock in dimethyl sulfoxide
(DMSO). Embryos were kept continuously in HUA at 14°C
until fixation. To arrest cell cycle at M-phase, dejellied stage
11.0 embryos were incubated in a solution of 10 M no-
codazole (Sigma) in 0.1 MMR at 14°C until fixation.
Nocodazole was diluted from a 10 mg/ml frozen stock in
DMSO. All embryos were fixed in MEMFA (100 mM
Mops, pH 7.4, 2 mM EGTA, 1 mM MgSO4, 4% formalde-
hyde) and stored in methanol at 20°C.
RNAs and microinjection
Synthetic capped RNAs for microinjection were synthe-
sized by in vitro transcription using mMessage mMachine
kit (Ambion) and purified following manufacturer’s instruc-
tions. Bcl-2 RNA was transcribed from pRC/CMV (In-
vitrogen, gift from Dr. T. Sato). Bcl-2G145A RNA was
transcribed from pRC/CMV, subcloned from pGEM4Z (gift
from Dr S. Korsmeyer; Yin et al., 1994). GFP RNA was
transcribed from pCS2 (gift from Dr A. Hemmati-
Brivanlou), subcloned from pEGFP-N1 (Clontech).
X-NotchICD and X-Delta-1STU RNAs were transcribed from
pCS2 (gifts from Dr C. Kintner).
All RNAs were injected into either one or both blas-
tomeres of two-cell stage embryos in 4% Ficoll, 1 MMR.
The uninjected side was used as an internal control. For
negative control, embryos were similarly injected with GFP
RNA. RNAs were injected in a volume of 5 nl at concen-
trations of 20–300 pg/nl. Embryos were grown to neurulae
stages and then fixed.
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Animal caps assay and RT-PCR analysis
For animal cap experiments with RNA microinjection,
animals caps were excised at stage 8.5–9.5 and cultured in
1 LCMR (66 mM NaCl, 1.33 mM KCl, 0.33 mM CaCl2,
0.17 mM MgCl2, 5 mM Hepes, pH 7.2) supplemented with
0.1% BSA and antibiotics (penicillin and streptomycin 100
g/ml; gentamycin 50 g/ml) until stage 19. RNA extrac-
tion was performed using RNA-Bee (Tel-Test, Inc.), fol-
lowed by isopropanol precipitation. The following primer
pairs used for RT-PCR analysis have been previously de-
scribed: EF1 for 25 cycles (Agius et al., 2000), XSox-2 for
25 cycles (Mizuseki et al., 1998), and XBra for 30 cycles
(Agius et al., 2000). PCR products were analyzed on 2%
agarose gel stained with Sybr-Gold (Molecular Probes) and
visualized using the Fluoroimager (AP Biotech).
Whole-mount TUNEL staining
Whole-mount TUNEL protocol was performed as previ-
ously described (Hensey and Gautier, 1998). Briefly, em-
bryos stored in methanol were rehydrated in PBS, perme-
ablized in PBT (0.2% Tween 20 in PBS), washed in PBS,
and incubated in 150 U/ml terminal deoxynucleotidyltrans-
ferase (GIBCO BRL) and 0.5 M dioxigenin–dUTP
(Roche). The reaction was stopped in PBS/1 mM EDTA, at
65°C, followed by washes in PBS. Detection and chromo-
genic reaction was carried out according to Harland (1991).
The embryos were blocked in PBT  20% goat serum,
followed by incubation with anti-dioxigenin antibody cou-
pled to alkaline phosphatase (Roche). Embryos were exten-
sively washed in PBS and the staining was developed using
nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl
phosphate substrates. The reaction was visible within 30
min, and embryos were viewed following dehydration in
methanol and mounted in benzyl benzoate/benzyl alcohol
2:1. Embryos were photographed on Zeiss Axiophot using
Zeiss Axiovision 2.05 imaging system.
Whole-mount in situ hybridization and
immunocytochemistry
Whole-mount in situ hybridization was performed as
previously described (Chitnis et al., 1995) using digoxyge-
nin-labeled antisense probes. Probes for N-Tub (Oschwald
et al., 1991), X-MyT1 (Bellefroid et al., 1996), XZicr-2
(Brewster et al., 1998), XMyoD (Hopwood et al., 1989),
XNgnr-1 (Ma et al., 1996), XSox-2 (Mizuseki et al., 1998),
and XDelta-1 (Chitnis et al., 1995) were prepared as de-
scribed previously.
Immunocytochemistry was performed according to Har-
land (1991). Embryos were blocked in PBT  20% goat
serum for 1 h and then incubated at 4°C overnight, with
anti-phosphorylated histone H3 antibody (1:1000, Upstate;
Saka and Smith, 2001) for identification of mitotic cells, or
with CM1 - anti P20 peptide of hCPP32 (1:2500, IDUN) for
activated caspases detection. Embryos were extensively
washed in PBS and the color reaction was developed using
nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phos-
phate substrates.
For double staining, the probe hybridization step of in
situ hybridization was performed first followed by immu-
nocytochemistry with anti-Bcl-2 antibody SC-100 (Santa
Cruz) or anti-GFP antibody B-2 (Santa Cruz). Detection of
antibodies was done using alkaline phosphatase conjugates
with Fast Red (Roche) or 5-bromo-4-chloro-3-indolyl phos-
phate. The alkaline phosphatase was then inactivated by
incubation in PBS containing 0.1 M EDTA at 65°C for 30
min. Unilaterally microinjected embryos were sorted based
on which half was injected, indicated by immunocytochem-
istry. Some of the embryos stained with Fast Red were
washed in 100% ethanol for 30 min to remove the red
coloration before being subjected to the further chromo-
genic reactions. The digoxygenin-labeled probe was de-
tected and visualized as described above, using nitro blue
tetrazolium and 5-bromo-4-chloro-3 indolyl phosphate sub-
strates.
All whole-mounts were photographed as described for
TUNEL. Quantification of N-Tub expression was performed
by measuring the area occupied by N-Tub-positive cells
using SCION Image. The area of choice on the embryo was
outlined on the image obtained from the Axiovision 2.05
system and measured.
Embedding and sectioning
Cleared embryos were washed in xylene, 1 5 min, 1
30 min. This was followed by a 30-min incubation in xy-
lene:paraplast (1:1) at 55°C. Embryos were then transferred
to paraplast and incubated for 3 30 min at 55°C. Embryos
were positioned in molds, allowed to set overnight, and
10-m sections were cut. Sections were dewaxed in
Hemo-De (Fisher), mounted, counterstained with eosin, and
photographed on a Zeiss Axioplan microscope using a Zeiss
Axiovision 2.05 imaging system.
Western blot analysis
Embryos from stages 15 and 25 were collected and
frozen in liquid nitrogen. Embryos were homogenized in
XB buffer (100 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2, 10
mM potassium Hepes, pH 7.7, 50 mM sucrose), and cen-
trifuged at 13,000 rpm for 15 min at 4°C to remove the
debris. The supernatant was then collected and used for
Western blot analysis. Western blot analysis was performed
using anti-Bcl2 antibody SC-100 (Santa Cruz) and PVDF
membrane filters (Immobilon, Millipore). Signals were vi-
sualized using chemiluminescence (Amersham).
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Results
Occurrence of PCD is independent of cell proliferation
To address the possible role of PCD during early neural
development, we first determined whether PCD requires or
is dependent upon the wave of cell division taking place
within the neural plate. Indeed, the similarity between the
spatio-temporal pattern of both proliferation and cell death
suggests possible relationships and interaction between
these physiological mechanisms in the regulation of the
absolute number of cells within the developing neuroecto-
derm. Therefore, we investigated the spatio-temporal pat-
terns of PCD in the absence of cell proliferation. Inhibition
of cell proliferation was achieved by incubating the embryo
in a mixture of HUA, which inhibits DNA synthesis in early
S-phase of the cell cycle (Harris and Hartenstein, 1991).
The effect of HUA on cell proliferation was monitored by
Fig. 1. Occurrence of PCD within the neuroectoderm is independent of cell proliferation. (A, B, E, F) Embryos shown in dorsal orientation; (C, D) embryos
shown in lateral orientation; all embryos are cleared and shown with anterior to the left. (A, B) Blue lines indicate the position of the dorsal midline. (A–D)
Whole-mount TUNEL staining of stage 15 embryos. (A, C) Control embryos incubated in DMSO; (B, D) embryos incubated in HUA (see Materials and
methods). (E, F) Immunocytochemistry with anti-phosphorylated histone H3 in stage 15 embryos: (E) DMSO control; (F) HUA-treated embryo.
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Fig. 2. Effect of Bcl-2 expression on programmed cell death in vivo. All injected embryos were injected at two-cell stage in both blastomeres. All embryos
are shown in dorsal orientation with anterior to the left; TUNEL-stained embryos were cleared. (A–F) Effect of expression of human Bcl-2 on PCD during
early neurogenesis. (A–C) Whole-mount TUNEL staining in embryos at stage 13; (A) uninjected control; (B) embryo injected with GFP mRNA (100 pg/nl);
(C) embryo injected with Bcl-2 mRNA (100 pg/nl). (D–F) Whole-mount immunocytochemistry with antibody against activated caspases, CM1, in embryos
at stage 13: (D) uninjected control; (E) embryos injected with GFP mRNA (100 pg/nl); (F) embryo injected with Bcl-2 mRNA (100pg/nl). (G–L) Levels of
PCD inhibition by wild-type and mutant Bcl-2. (G–K) Whole-mount TUNEL staining in stage 16 embryos: (G) uninjected control; (H) embryo injected with
GFP mRNA (20 pg/nl); (I) embryo injected with G145A mutant (20 pg/nl, see text); (J) embryos injected with wild-type Bcl-2 mRNA (20 pg/nl). (K)
Quantification of the inhibition on TUNEL done by the comparison of the percentage of TUNEL-positive embryos in each experimental batch with that from
the uninjected control: Control: 100%; GFP: 104.0  15.8%; G145A: 56.3  8.6%; Bcl-2: 25.2  4.6%; DMQD: 48.5  17.2%. (L) Embryos injected with
wild-type or G145A Bcl-2 mRNAs were collected at stages 15 and 25, and processed for Western blotting using specific anti-Bcl-2 antibodies.
35W. Yeo, J. Gautier / Developmental Biology 260 (2003) 31–45
staining mitotic cells by immunocytochemistry with anti-
bodies specific for phosphorylated histone H3, a specific
marker of mitotic cells, thus establishing the efficacy of
HUA treatment (Saka and Smith, 2001). Embryos incubated
in HUA at stage 11 exhibited a dramatic decrease in the
level of proliferation, seen by the number of mitotic cells,
compared to that of the controls incubated in DMSO (Figs.
1E and F). TUNEL staining was still present, despite the
dramatic decrease in cell proliferation in the HUA-treated
embryos (Figs. 1A–D). The DMSO-treated controls dis-
played the typical TUNEL staining pattern: within the an-
terior neuroectoderm and posterior neural folds as expected
for stage 15 (Figs. 1A and C; Hensey and Gautier, 1998).
The HUA-treated embryos also displayed a similar pattern
of staining, although at a higher level compared to the
DMSO controls (Figs. 1A and B). Transverse sections of
HUA-treated embryos showed that staining was still con-
fined within the neuroectoderm, typical of PCD in the neu-
roectoderm (data not shown; Hensey and Gautier, 1998).
We never observed any significant staining in tissues other
than the neuroectoderm in stages 13 to 17, similar to that
observed in untreated controls. Because variability exists in
TUNEL staining (Hensey and Gautier, 1998), we quanti-
tated the level of TUNEL staining by counting the embryos
with more than 30 stained nuclei in the dorsal ecotoderm in
both HUA-treated and DMSO-control batches; 83.0 
27.9% of HUA-treated embryos (454 embryos) exhibited
positive staining, whereas only 34.3  26.8% of DMSO
embryos (425 embryos) exhibited positive staining. In ad-
dition, the density of staining was reproducibly stronger
within the anterior neuroectoderm and posterior neural folds
compared to that of the DMSO-treated control (Figs. 1C and
D). In addition, TUNEL staining in HUA-treated embryos
was greatly reduced when the embryos were microinjected
with Bcl-2 mRNA at the two-cell stage (data not shown),
demonstrating that the TUNEL staining observed in HUA-
treated embryos was due to PCD. We conclude that PCD
within the neuroectoderm during primary neurogenesis is
not dependent on normal cell proliferation taking place
within the neural plate. This indicates that the regulation of
the absolute cell number of the neuroectoderm is not the
primary role of PCD within the neuroectoderm.
Bcl-2 inhibits PCD in vivo
To assess the possible consequences of inhibiting PCD
during the development of the neuroectoderm, we designed
experimental conditions to inhibit PCD in vivo. We chose to
express human Bcl-2 protein to prevent the occurrence of
PCD (Fig. 2). We have previously demonstrated that human
Bcl-2 mRNA microinjection is very effective in inhibiting
apoptosis triggered by irradiation in Xenopus eggs (Hensey
and Gautier, 1997). We used two different assays to identify
cells undergoing apoptosis: TUNEL staining, which identi-
fies cells undergoing DNA fragmentation, and immunocy-
otchemistry, with an antibody (CM1) that specifically rec-
ognizes the activated forms of caspases (Gavrieli et al.,
1992; Srinivasan et al., 1998). Importantly, both methods
gave very similar staining patterns (Figs. 2A–F, data not
shown). Specifically, CM1 staining was mostly confined
within the dorsal region of early neurulae, similar to
TUNEL staining (Figs. 1 A and D; Hensey and Gautier,
1998). This shows that the spatio-temporal pattern of
caspase activation correlates with that of DNA fragmenta-
tion. Embryos injected with Bcl-2 mRNA showed strong
reduction in both TUNEL and CM1 staining (Figs. 2E and
F), whereas those injected with GFP mRNA exhibited stain-
ings confined to the neuroectoderm, similar to those ob-
served for the noninjected controls (Figs. 2B and C). Hence,
PCD during early development of the Xenopus embryo can
be specifically inhibited in vivo by the expression of exog-
enous human anti-apoptotic Bcl-2. Furthermore, TUNEL
staining is reduced significantly following microinjections
with DMQD, a synthetic peptide inhibitor of the effector
caspase Caspase-3, suggesting that Caspase-3 plays a sig-
nificant role in bringing about PCD in the neuroectoderm
(Fig. 2K; Talanian et al., 1997).
Studies in mammalian cells showed that the heterodimer-
ization of Bcl-2 with pro-apoptotic protein Bax prevents
Bax-dependent release of cytochrome c from the mitochon-
dria and subsequent caspase activation (Chao and Kors-
meyer, 1998; Desagher and Martinou, 2000). The G145A
mutant form of Bcl-2 carries a missense mutation in its BH3
domain, impairing its interaction with Bax. As a result, the
G145A mutant exhibits 30% of the wild-type anti-apoptotic
activity (Yin et al., 1994). To determine if the exogenous-
Bcl-2 protein inhibited apoptosis in a manner similar to that
described in mammalian cells, we compared the effects of
expressing wild-type Bcl-2 and the G145A mutant on PCD.
Embryos injected with GFP mRNA did not exhibit any
reduction in TUNEL staining, beyond that of the variability
of the assay (Figs. 2G, H, and K). Embryos injected with the
mutant G145A mRNA exhibited significantly higher
TUNEL staining than that of embryos injected with wild-
type Bcl-2 mRNA (Figs. 2I, J, and K; t-test value 0.05),
whereas the levels of expression for each protein were
similar (Fig. 2L). However, the mutant still retained partial
ability to inhibit PCD; embryos injected with the G145A
mutant still displayed a significant reduction in overall
TUNEL staining when compared to the unaffected unin-
jected and GFP controls (Fig. 2K, t-test value 0.05). This
confirms that the reduction in TUNEL staining observed in
Bcl-2-injected embryos is not due to a nonspecific effect of
overexpressing the protein in these embryos. This further
shows that reduction of TUNEL in Bcl-2-injected embryos
is due to the documented anti-apoptotic activity described in
mammalian cells. This strongly suggests that apoptosis
within the neuroectoderm occurs via the mitochondrial
pathway, regulated by interactions between proteins with
functions homologous to that of Bcl-2 and Bax.
Taken together, these experiments establish that PCD
can be reproducibly inhibited in vivo during early neuro-
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genesis and that Bcl-2 mRNA microinjection can be used as
a reliable way to assess consequences of PCD inhibition on
development.
PCD inhibition leads to an increase in neuronal cell
numbers
We assessed the consequences of PCD inhibition on
neural development following microinjection of Bcl-2
mRNA into one blastomere of two-cell stage embryos.
Injected halves were visualized by immunocytochemistry
using antibodies against GFP or Bcl-2. One example of GFP
and N-Tubulin double-staining showing the injected half is
presented in Fig. 3H (see Materials and methods). The red
coloration indicating the injected half was then washed off
after the injected embryos were sorted out based on which
half had been injected, and before the examination of the
expression pattern of any molecular marker. The conse-
quence of PCD inhibition on the development of the neural
plate was first monitored by following the expression pat-
tern of N-Tubulin, an early marker of neuronal differentia-
tion (Fig. 3A; Oschwald et al., 1991). Inhibition of PCD via
Bcl-2 expression in one side of the embryo resulted in the
lateral expansion of N-Tub expression domain on the in-
jected side compared to that of the uninjected side (Figs.
3C–F; 30.5% in 400 Bcl-2-injected embryos). Control in-
jections, using GFP mRNA, did not result in any significant
difference in N-Tub expression pattern between the injected
and uninjected sides compared to that observed in unin-
jected controls (Figs. 3A and B). Transverse sections of
embryos exhibiting N-Tub expansion showed that the do-
main of N-Tub-positive cells corresponding to the position
of prospective sensory neurons was expanded laterally (Fig.
3G). In addition, the medial domain corresponding to the
motor neurons was expanded as well in slightly older em-
bryos (data not shown).
To test that Bcl-2 did not directly modify ectodermal cell
fate, animal cap explants from embryos overexpressing
Bcl-2 were monitored for the expression of XSox-2, an early
neural marker, and Xbra, a marker for axial mesoderm (Fig.
3I). Bcl-2-injected animal caps did not acquire mesodermal
or neural identity as seen by the lack of XSox-2 and XBra
expression. However, XSox-2 was induced in animal caps
overexpressing neural inducer, Chordin. Furthermore, the
effect of PCD inhibition on N-Tub expression, via Bcl-2
overexpression, did not vary within the range of Bcl-2
mRNA microinjected (0.25–1.5 ng/embryo) that did not
show any differential level of PCD inhibition (data not
shown). This establishes that the expansion of N-Tub is
specifically due to the inhibition of PCD, via the overex-
pression of Bcl-2, and suggests that PCD may regulate the
development of primary neurons.
The nonneuronal domain between the lateral and the
medial domains expressing N-Tub was also expanded at the
posterior region of the embryo (Figs. 3C–F) and we fol-
lowed the expression pattern of XZicr-2, which is expressed
within this region (Fig. 3J; Brewster et al., 1998). Bcl-2-
injected embryos showed an expansion in XZicr-2 expres-
sion domain in the posterior region of the embryo, corre-
sponding to the region between the medial and lateral
neuronal domains (Fig. 3L; 24.3% in 58 Bcl-2-injected
embryos), in agreement with the expanded N-Tub-negative
region observed earlier. However, the expansion observed
for XZicr-2 was modest, compared to that observed for
N-Tub, in terms of both the fraction of embryos displaying
the expansion and the size of the expansion itself. GFP-
injected control embryos did not exhibit such expansion
(Fig. 3K). This confirms that PCD inhibition affects non-
neuronal cells within the neuroectoderm as well, albeit at a
less significant level than that observed for N-Tub.
We used two different methods to quantitate the effect of
PCD inhibition on the expansion of the lateral N-Tub do-
main (Fig. 4). In the first method, we used N-Tub-positive
cell count as the read-out (Fig. 4C). N-Tub-positive cells
were counted for each half in the embryos injected with
Bcl-2. The ratio of N-Tub-positive cells in the injected to
uninjected was calculated (illustrated in Fig. 4A). The av-
erage ratio of N-Tub-positive cells in Bcl-2-injected half/
uninjected half in the Bcl-2-injected batch was 1.43. This
was significantly higher than the average ratio obtained for
the entire GFP-injected batch, which was 0.94 (Fig. 4C,
t-test value 0.01). In the second method, we used the area
of N-Tub-positive domain as the read-out (Fig. 4D). The
area of the N-Tub domain on either side of the unilaterally
injected embryos was drawn and measured using SCION
Image software. The ratio between areas of N-Tub domain
of the injected and uninjected sides was calculated (illus-
trated in Fig 4B). The average ratio of Bcl-2-injected was
1.47, whereas that of the GFP-injected batch was 0.97 (Fig.
4D, t-test value 0.01). Thus, when PCD was inhibited in
one-half of the embryo, the number and the area of N-Tub-
positive cells increased in that half. Taken together, these
results confirm that PCD inhibition leads to increases in
both the number of N-Tub-positive cells and the size of the
neuroectoderm, supporting the qualitative observations
(Fig. 3). Therefore, inhibition of PCD results in the disrup-
tion of normal neuronal development as seen by ectopic
N-Tub-positive cells, accompanied by an increase in neural
tissue.
Absence of PCD leads to expansion of neural tissue
N-Tub expression occurs as a consequence of the neuro-
genic cascade, which is initiated from the time of neural
induction (Sasai, 1998). The abnormal expression pattern of
N-Tub during PCD inhibition suggests that disruptions
along this cascade have occurred as a result of PCD inhi-
bition. As PCD occurs throughout the period during which
neuronal differentiation takes place in the posterior neuro-
ecotoderm, we first investigated the spatial expression of
genes, specific to processes regulating neuronal differenti-
ation within the three domains of primary neurogenesis
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Fig. 3. Consequences of PCD Inhibition of PCD on primary neurogenesis. (A–F) Effect of PCD inhibition on N-Tub expression in stage 15 embryos as seen
by whole-mount in situ hybridization; (A) uninjected control; (B) embryo injected unilaterally with GFP mRNA; (C–F) embryo injected unilaterally with
Bcl-2 mRNA. (C–F) Range of effect of PCD inhibition on domains of N-Tub expression. Injected embryos were injected at two-cell stage in one blastomere
at 100–200 pg/nl. Arrows in (B-F) indicate the half that had been injected. (G) Transverse section taken from position indicated by the blue line from the
embryo in (C). Arrows in (G) indicate the ectopic N-Tub-positive cells in the dorsal ectoderm; n, notochord; s, presomitogenic mesoderm; nf, neural fold.
(H) Embryo injected unilaterally with GFP mRNA and subjected to immunocytochemistry with anti-GFP antibodies (red) and in situ hybridization with
N-Tub probe (black). The injected half, stained in red, is indicated by an arrow. (I) RT-PCR analysis of stage 19 animal caps; Cont, uninjected control; Bcl-2,
embryos injected with Bcl-2 mRNA (100 pg/nl); Chd1, Chordin mRNA (20 pg/nl); Chd2, Chordin mRNA (100 pg/nl); Emb, whole embryo; RT,
RT-negative control. Primers specific for EF-1, XSox-2, and Xbra were used. (J–L) Effect of PCD inhibition on XZicr-2 expression in stage 15 embryos
as seen by whole-mount in situ hybridization; (J) uninjected control; (K) embryo injected unilaterally with GFP mRNA; (L) embryo injected unilaterally with
Bcl-2 mRNA; red arrow indicates the posterior region which is expanded in the Bcl-2-injected half. Injected embryos were injected at two-cell stage in one
blastomere at 100 pg/nl. Arrows indicate the injected halves. All embryos are shown in the dorsal orientation.
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(Fig. 5). Inhibition of PCD resulted in the expansion of the
lateral domain of XMyT-1 expression corresponding to the
position of sensory neurons (Fig. 5C; 30.4% in 204 Bcl-2-
injected embryos). This effect is highly similar to that ob-
served for N-Tub following PCD inhibition, in that at the
stage examined, only the lateral domain exhibited signifi-
cant expansion. Expression of XNgnr-1, which lies up-
stream of XMyT-1, was also affected by the inhibition of
PCD (Fig. 5F). In addition, XNgnr-1 exhibited a more
significant phenotype following PCD inhibition, compared
to its downstream genes, in that all three prospective neu-
ronal domains were expanded at the stage examined (do-
mains indicated by the red arrows in Fig. 5F). Further
experiments revealed that the penetrance of embryos exhib-
iting expansion in XNgnr-1 was higher than that of N-Tub
(49.6% for XNgnr-1 vs 30.5% for N-Tub in 300 embryos
at 1.5 ng/embryo of Bcl-2 mRNA; t-test value 0.05).
Control embryos microinjected with GFP mRNA did not
exhibit any significant changes in the expression of either
gene when compared to the uninjected controls (Figs. 5B
and E). These observations, together with the effect on
N-Tub expression, indicate that the lack of PCD results in
the expansion of gene expressions regulating neuronal dif-
ferentiation, suggesting that PCD is likely to play a role
during the differentiation of the posterior neuroecotoderm.
We wanted to determine if all neural tissues would be
affected by the inhibition of PCD, in particular the anterior
neural tissue, as PCD is at times localized within the ante-
rior regions (Hensey and Gautier, 1998). We monitored
XSox-2 expression, which occurs shortly after neural induc-
tion, in a pan-neural manner (Mizuseki et al., 1998). Ex-
pression of XSox-2 in the posterior neuroectoderm was
expanded in the Bcl-2-injected side of the embryo, com-
pared to that of the uninjected side, in agreement with the
expansion of the domains of genes involved with differen-
tiation of the posterior neuroectoderm (Fig. 5I; 38.0% in 84
Bcl-2-injected embryos). There was no significant differ-
ence between the pattern of XSox-2 expression in the in-
jected and uninjected sides of GFP-injected embryos, com-
pared to that of the uninjected controls (Figs. 5H and K).
Fig. 4. Quantification of N-Tubulin-expressing cells and N-Tubulin domains. (A, C) Effect of PCD inhibition on number of N-Tub-positive cells. (C) Average
ratios of cell counts from the injected sides (red dots in (A)) to that of the uninjected sides (blue dots in (A)) were calculated for Bcl-2-injected batch (red
bar) and GFP-injected batch (blue bar; see Materials and Methods). (B, D) Effect of PCD inhibition on the area covered by N-Tub positive cells. (D) Average
ratios of area measurements from the injected sides (outlines in red in (B)) to that of the uninjected uninjected sides (outlined in blue in (B)) were calculated
for Bcl-2-injected batch (red bar) and GFP-injected batch (blue bar; see Materials and methods).
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Furthermore, XSox-2 expression in the anterior neuroecto-
derm was also expanded (Fig. 5L). This indicates that PCD
is required for the development of the anterior neuroecto-
derm, as well as for the posterior neuroecoterm.
To investigate whether inhibition of PCD affected me-
soderm tissues in addition to the neuroectoderm, we fol-
lowed the expression of XMyoD. XMyoD is a bHLH tran-
scription factor, expressed in the paraxial mesoderm,
involved in the somitogenic differentiation of the paraxial
mesoderm (Fig. 5M, Hopwood et al., 1989). Consistent with
our previous observation that PCD does not take place at
detectable levels within the paraxial presomitogenic meso-
derm (Hensey and Gautier, 1998), the expression of XMyoD
in the presomitogenic mesoderm in the Bcl-2-injected side
did not exhibit any difference from that of the uninjected
side (Fig. 5O).
PCD and neuronal differentiation
We decided to further investigate the regulation of PCD
occurring during the differentiation of the posterior neuro-
ectoderm. Differentiation of XNgnr-1-expressing cells is
regulated by lateral inhibition, via the interaction between
X-Notch-1 and X-Delta-1 (Bellefroid et al., 1996; Ma et al.,
1996). We first determined if the outcome of lateral inhibi-
tion would be affected by PCD inhibition as PCD could be
an alternative to neuronal cell fate for a subpopulation of
cells undergoing lateral inhibition. Indeed, the pattern of
TUNEL (Figs. 6A and B) overlaps with that of X-Delta-1
(Fig. 6C) and XNgnr-1 (Fig. 6D) in midneurulae (stage 14).
Any effect on the outcome of lateral inhibition results in
changes of the density of N-Tub-positive cells within the
three neuronal domains (Chitnis et al., 1995). Density of
N-Tub-positive cells in embryos exhibiting expanded N-Tub
expression following PCD inhibition was derived from the
cell count and area measurement quantifications (Fig. 4).
Data obtained showed that there was no change in the
density of N-Tub-positive cells in embryos with increased
neuronal cell counts (number/area for Bcl-2-injected em-
bryos  0.97), compared to that obtained for GFP-injected
control embryos (number/area for GFP-injected embryos 
0.97). This indicates that PCD inhibition does not affect the
outcome of lateral inhibition. In addition, this suggests that
lateral inhibition still restricts the number of cells specified
to express N-Tub within the expanded neuronal domains
following PCD inhibition. Overexpression of dominant neg-
ative X-Delta-1STU interferes with the activity of the endog-
enous X-Delta-1 and biases the outcome of lateral inhibi-
tion, resulting in an increase in the number of differentiating
neurons within the neuronal domains (Fig. 6H; Chitnis et
al., 1995). However, there did not appear to be any appre-
ciable increase in TUNEL staining in the half microinjected
with X-Delta-1STU mRNA (Figs. 6F and G; 139 embryos).
As X-DeltaSTU interferes with the outcome of lateral inhi-
bition, this strengthens the idea that PCD does not take place
downstream of lateral inhibition.
We wished to determine if PCD is associated with dif-
ferentiation of the neuroectoderm. The overexpression of
constitutively active X-NotchICD prevented differentiation in
the neuroecotoderm, leading to an expansion of uncommit-
ted neural cells, seen as in the increase in XSox-2 (Fig. 6K)
and reduction in N-Tub expressions (Fig. 6L, Coffman et al.,
1993). This was performed in the absence of cell prolifer-
ation via HUA treatment to enhance TUNEL staining with-
out affecting the neurogenic effect of either X-NotchICD or
X-DeltaSTU overexpression (Figs. 6E–L; Coffman et al.,
1993). In embryos microinjected unilaterally with X-NotchICD,
the injected half exhibited a significant reduction in TUNEL
staining, compared to the uninjected half (Figs. 6I and J; 51%
of 93 embryos). TUNEL was excluded from the cells overex-
pressing X-NotchICD within regions stained in green (GFP
tracer; Figs. 6I and J). Reduction of cell death in the half
overexpressing X-NotchICD suggests that PCD is associated
with differentiation of the neural cells. Therefore, PCD is
reduced when the neural cells are prevented from differentiat-
ing, linking the occurrence of PCD to neuronal differentiation.
Discussion
Early neural cell death
The PCD we have analyzed takes place within a mixed
population of actively proliferating neural precursors and
new postmitotic neuroblasts (de la Rosa and de Pablo,
2000). Importantly, occurrence of PCD during this early
stage sets it apart from cell death occurring in terminally
differentiated neurons as a result of lack of neurotrophic
support for their survival (Raff et al., 1993). At the stages
analyzed (14–16), PCD affects neural precursors and young
neuroblasts have not yet acquired the connective properties
characteristic of differentiated neurons and are not depen-
dent on neurotrophic factors for survival. This is reminis-
cent of PCD occurring in the proliferative and newly post-
mitotic regions of the neuroproliferative regions in the CNS
of mouse embryos (Blaschke et al., 1996, 1998). We have
demonstrated that disruption of early neural PCD results in
abnormal neurogenesis, indicating that it is a prerequisite
for early neural development.
The major consequence of cell death inhibition is the
presence of supernumerary cells or “rescued cells,” which
are cells that were meant to die but were prevented from
doing so. Overexpression of Bcl-2 in neurons of transgenic
mice results in the occurrence of supernumerary neurons
(Martinou et al., 1994). Similarly, we demonstrated that
PCD inhibition through overexpression of Bcl-2, in Xeno-
pus early neural development, results in increased number
of both neural and neuronal cell types. Consequences of
PCD inhibition could be either cell-autonomous, non-cell-
autonomous or both. A cell-autonomous effect of PCD
inhibition would lead to rescued cells adopting alternative
cell fates and resulting in increased domains of gene ex-
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pression within the neuroectoderm. A non-cell-autonomous
effect could arise if the rescued cells influence neighboring
cells to adopt alternative cell fates (Ruiz i Altaba, 1994).
Since we are not able to monitor the fate of rescued cells
from the point when they are prevented from dying, we
cannot distinguish between these possibilities which are not
mutually exclusive. Nevertheless, either possibility predicts
that the rescued cells are able to perform biological func-
tions, rather than to remain nonfunctional.
PCD in the neurogenic cascade
The spatio-temporal pattern of PCD during primary neu-
rogenesis overlaps with the patterns of expression of several
of the genes regulating early neural development (Hensey
and Gautier, 1998). Indeed, both X-Delta-1 and XNgnr-1
expressions display a significant degree of overlap with
TUNEL during primary neurogenesis. However, neither X-
Delta-1 nor XNgnr-1 patterns are completely superimpos-
able with that of TUNEL. DNA fragmentation of apoptotic
cells detected by TUNEL is very transient and TUNEL
detection is possible only within a small window of time
during apoptosis. The effect of PCD inhibition on the ex-
pression of these genes may suggest the position(s) in the
neurogenic cascade at which PCD takes place, which is
important in unraveling the role PCD plays during neuro-
genesis. There is an increase in the amount of cells deter-
mined to become neurons following PCD inhibition, indi-
cated by the increase in XNgnr-1 expression domains
(Chitnis et al., 1995; Ma et al., 1996). Expression of neu-
ronal genes downstream of XNgnr-1, such as XMyT-1 and
N-Tub, is increased as well. Increase in the expression of
these downstream genes could be solely due to the increase
in XNgnr-1 cells, implying that PCD inhibition probably
occurs upstream of or at the same level of XNgnr-1 expres-
sion along the neurogenic cascade. The effect of PCD in-
hibition on XNgnr-1, which is more significant than that on
either XMyT-1 or N-Tub, supports this hypothesis. More
significantly, XNgnr-1 activates lateral inhibition, which
regulates the density of neurons with the XNgnr-1 domains,
by inducing X-Delta-1 (Chitnis et al., 1995; Ma et al., 1996).
If PCD is a fate regulated by lateral inhibition or if PCD
occurs downstream of lateral inhibition, the densities of
XMyT-1 and N-Tub should be increased. We have shown
that the density of N-Tub-positive cells within the neuronal
domains is not affected by PCD inhibition. This indicates
that PCD does not take place in cells which have undergone
selection by lateral inhibition. Taken together, our data
strongly suggest that ectopic neurons arise as a consequence
of increased XNgnr-1-positive cells, implying that PCD
occurring before or upon the onset of differentiation has
been inhibited, thus positioning PCD upstream of, or at the
same level as, XNgnr-1 expression. One implication is that
PCD is associated with the process of neuronal determina-
tion, which is regulated by XNgnr-1. The expression of
XNgnr-1 persists throughout the neurulation stages, sug-
gesting continuation of neuronal determination beyond the
initial appearance of N-Tub, and this could account for the
continued occurrence of PCD during the neurulation stages.
PCD and neuronal determination
An attractive hypothesis is that PCD is a novel form of
regulation during the transition of neural cells that are un-
determined and undifferentiated to cells which have been
determined to differentiate into neurons. Constitutive Notch
signaling results in the reduction of neuronal determination,
by maintaining the neural cells in an uncommitted nature, as
seen by the reduction in XNgnr-1 and increase in XSox-2
expressions (Coffman et al., 1993; Ma et al., 1996). Over-
expression of X-NotchICD also results in the reduction of
PCD occurring within the neuroectoderm (Figs. 6I and J).
Therefore, by preventing the cells from differentiating via
constitutive Notch signaling, PCD is no longer taking place.
This supports the idea that effects of PCD inhibition dis-
cussed earlier might be the consequence of PCD inhibition
occurring at the level of XNgnr-1 expression, which deter-
mines the neuroecotoderm for differentiation. However, in-
crease in neuronal density mediated by dominant negative
X-Delta-1STU does not alter the pattern of PCD. The effect
of X-Delta-1STU may be too subtle to be detected, compared
to that of X-NotchICD. As TUNEL displays a significant
level of variability (Hensey and Gautier, 1998), slight
changes to the level of TUNEL may go undetected. Since
X-DeltaSTU interferes with the outcome of lateral inhibition,
this is in agreement with the conclusion that the majority of
PCD observed during primary neurogenesis is independent
of events taking place downstream of lateral inhibition.
Inhibition of PCD also leads to the expansion of undiffer-
entiated neural cells, expressing XSox-2, with the potential
to become XNgnr-1-expressing neurons. It will be interest-
ing to assess the effect of modulating XNgnr-1 expression
on PCD, since we cannot rule out that the decrease in PCD
following X-NotchICD overexpression may be due to its
ability to inhibit apoptosis, as suggested by observations
made in hematopoietic cells overexpressing X-NotchICD
(Miele and Osborne, 1999).
PCD and proliferation in the neuroectoderm
The spatio-temporal pattern of division is similar to that
of PCD, suggesting a possible connection between these
two physiological processes (Hartenstein, 1989; Saka and
Smith, 2001). The balance between cell death and cell
division is essential to maintain cell number within a tissue
and PCD could participate in regulating cell number within
the neuroectoderm (Conlon and Raff, 1999; Evan et al.,
1995). However, we do not believe that the primary role of
PCD is to maintain absolute cell numbers in the developing
neuroectoderm. Neural plates in which one cell cycle has
been prevented, containing half the normal number of cells
as a result, still undergo “patterned” PCD. Therefore, the
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Fig. 5. Consequences of PCD inhibition on the expression of genes involved in primary neurogenesis. Effect of PCD inhibition on various neural markers
is shown by whole-mount in situ hybridization. All injections were carried out on two-cell stage embryos in one blastomere; arrowheads in panels with
injected embryos indicate the injected half. All embryos are shown in the dorsal orientation except for those in (M–O), which are shown in anterior orientation.
(A, D, G, J, M) Uninjected control embryos; (B, E, H, K, N) embryos injected with GFP mRNA (100 ng/nl); (C, F, I, L, O) embryos injected with Bcl-2
mRNA (100 ng/nl). Embryos were processed for in situ hybridization at stages 14–15 using probes specific for (A–C) XMyT-1, (D–F) XNgnr-1; red arrows
in (F) indicate the three domains of neuronal differentiation in the Bcl-2-injected half and green arrows indicate the domains in the uninjected half, (G–L)
XSox-2; red and green lines illustrate the expansion of XSox-2 expression in the Bcl-2-injected half in (G) and (L); the red arrow in (L) indicates the expanded
anterior neuroecotoderm in the injected half; (M–O) XMyoD.
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deficit in cell numbers of these HUA-treated embryos is not
compensated by reduction in apoptosis.
It has also been proposed that cell death fate might
require a certain number of divisions in some systems.
However, PCD still occurs when the single round of cell
division within the neuroectoderm between stages 12 and 16
is blocked. This demonstrates that the number of cell divi-
sions does not determine the occurrence of PCD within the
neuroectoderm. Interestingly, cell fate determination during
primary neurogenesis is independent of cell division as well,
confirming the more intimate interaction cell death has with
the process of differentiation than it has with proliferation
(Harris and Hartenstein, 1991).
Whereas the spatio-temporal pattern of PCD remains
similar to that observed in control embryos, the amount of
TUNEL staining is increased in HUA-treated embryos. The
reasons for such an increase are not well understood. Part of
the increased staining could possibly be a consequence of
HUA treatment, following the block of cell cycle progres-
sion in S-phase. The ends of DNA replication intermediates,
arising from incomplete replication, can potentially be la-
beled by TUNEL. However, inhibition of proliferation by
HUA is not restricted to the neuroectoderm; cell division in
other proliferating tissues, such as the lateral and ventral
ectoderm, of the embryos is blocked as well, as seen in the
overall reduction in immunocytochemistry staining with
antibodies directed against phosphorylated histone H3
(Saka and Smith, 2001). Since there is no TUNEL staining
observed within tissues other than the neuroectoderm, we
can rule out the possibility that the increase in TUNEL
staining is due to the labeling of blocked replicative struc-
tures. Furthermore, embryos treated with nocodazole, which
blocks cell cycle progression in M-phase by interfering with
the mitotic spindle (Hoebeke et al., 1976), also display
increased TUNEL staining. Nocodazole-treated embryos
still display a spatio-temporal TUNEL pattern similar to that
in control embryos (data not shown).
Alternatively, blocking cell cycle progression could in-
crease the sensitivity of TUNEL staining, possibly by
lengthening the window of time during which apoptotic
cells can be detected by TUNEL. Under normal conditions,
TUNEL staining is absent in a fraction of embryos during
gastrulation and neurulation (Hensey and Gautier, 1998).
This may be due to the rapid degradation of apoptotic cells
with a clearance time of 1 h or less (Jacobson et al., 1997).
It is conceivable that cell cycle inhibition slows down the
rate at which dying cells are degraded, thus allowing more
cells to be detected by TUNEL at a given time. It has to be
stressed that while HUA treatment enables better detection
Fig. 6. Effect of overexpression of X-NotchICD on PCD. (A–D) Comparison between PCD pattern and X-Delta-1 and XNgnr-1 expression patterns in stage
15 midneurulae; (A, B) whole-mount TUNEL staining; (C, D) whole-mount in situ hybridization with probes specific for (C) X-Delta-1 and (D) XNgnr-1.
(E–L) Effect of overexpression of X-Delta-1STU and X-NotchICD on neural development and PCD in embryos incubated with HUA; (E) uninjected control;
(F–H) embryos coinjected unilaterally with X-Delta-1STU and GFP mRNA (50 pg/nl); (I–L) embryos coinjected unilaterally with X-NotchICD mRNA (50
pg/nl) and GFP mRNA (50 pg/nl). Injected halves were visualized with immunocytochemistry with anti-GFP antibodies: green in (F, G, I, J); blue in (K);
red in (H, L). Arrows in (F–H) and (I–L) indicate the injected halves. The embryos were also subjected to TUNEL (black) in (E, F, G, I, J) or in situ
hybridization with probes specific for N-Tubulin (black) in (H, L), or XSox-2 (brown) in (K). All embryos are in the dorsal orientation.
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of apoptotic cells, we do not believe that it increases the
occurrence of PCD within the neuroectoderm.
In summary, we have shown that the inhibition of PCD
is possible through the overexpression of anti-apoptotic
Bcl-2 during early Xenopus embryogenesis. Using this sys-
tem, we show that PCD is required for normal neural de-
velopment in the early stages of embryogenesis; inhibition
of PCD disrupts normal primary neurogenesis. This estab-
lishes that some neural cells undergo PCD as part of the
normal neural development. XNgnr-1 domains are most
significantly affected by PCD inhibition, indicating that
PCD is most prominent at the level of neuronal determina-
tion, leading to an increase of determined cells which will
be subsequently selected for neuronal differentiation by
lateral inhibition. While PCD is not involved in the main-
tenance of absolute cell number in the neuroectoderm, it is
dependent on the amount of neuronal determination. By
maintaining the neural cells uncommitted, PCD is abro-
gated, supporting the idea that PCD is associated with
events that determine neural cells to become neurons.
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